News

Home / News

TSH Biopharm was invited to attend theinstitutional investor conference hosted by Concord Securities

TSH Biopharm was invited to attend theinstitutional investor conference hosted by Concord Securities

2024.12.16

...

More

AnnAnnouncement on behalf of major subsidiary,TOP PHARM.MEDICALWARE COMPANY LIMITED regarding BOD resolved to convene the extraordinary shareholders' meeting

AnnAnnouncement on behalf of major subsidiary,TOP PHARM.MEDICALWARE COMPANY LIMITED regarding BOD resolved to convene the extraordinary shareholders' meeting

2024.11.25

...

More

Announcement on behalf of major subsidiary,TOP Biological Technology Co.,Ltd.regarding BOD resolved to convene the extraordinary shareholders' meeting

Announcement on behalf of major subsidiary,TOP Biological Technology Co.,Ltd.regarding BOD resolved to convene the extraordinary shareholders' meeting

2024.11.25

...

More

TSH Biopharm Announces TFDA Approval of TYRVAYA® Nasal Spray for Dry Eye Treatment

TSH Biopharm Announces TFDA Approval of TYRVAYA® Nasal Spray for Dry Eye Treatment

2024.11.18

...

More

Announcement on behalf of major subsidiary,TOP Biological Technology Company Limited to Merge into TOP PHARM.MEDICALWARE COMPANY LIMITED

Announcement on behalf of major subsidiary,TOP Biological Technology Company Limited to Merge into TOP PHARM.MEDICALWARE COMPANY LIMITED

2024.11.15

...

More

 TSH Board of Directors Approved  the Consolidated Financial Statements For the Nine Months Ended September 30,2024

TSH Board of Directors Approved the Consolidated Financial Statements For the Nine Months Ended September 30,2024

2024.11.8

...

More